Correlation Between Avenue Therapeutics and Assembly Biosciences
Can any of the company-specific risk be diversified away by investing in both Avenue Therapeutics and Assembly Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avenue Therapeutics and Assembly Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Avenue Therapeutics and Assembly Biosciences, you can compare the effects of market volatilities on Avenue Therapeutics and Assembly Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avenue Therapeutics with a short position of Assembly Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avenue Therapeutics and Assembly Biosciences.
Diversification Opportunities for Avenue Therapeutics and Assembly Biosciences
0.67 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Avenue and Assembly is 0.67. Overlapping area represents the amount of risk that can be diversified away by holding Avenue Therapeutics and Assembly Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Assembly Biosciences and Avenue Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avenue Therapeutics are associated (or correlated) with Assembly Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Assembly Biosciences has no effect on the direction of Avenue Therapeutics i.e., Avenue Therapeutics and Assembly Biosciences go up and down completely randomly.
Pair Corralation between Avenue Therapeutics and Assembly Biosciences
Given the investment horizon of 90 days Avenue Therapeutics is expected to under-perform the Assembly Biosciences. In addition to that, Avenue Therapeutics is 2.08 times more volatile than Assembly Biosciences. It trades about -0.24 of its total potential returns per unit of risk. Assembly Biosciences is currently generating about -0.32 per unit of volatility. If you would invest 1,715 in Assembly Biosciences on November 3, 2024 and sell it today you would lose (314.00) from holding Assembly Biosciences or give up 18.31% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Avenue Therapeutics vs. Assembly Biosciences
Performance |
| Timeline |
| Avenue Therapeutics |
| Assembly Biosciences |
Avenue Therapeutics and Assembly Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Avenue Therapeutics and Assembly Biosciences
The main advantage of trading using opposite Avenue Therapeutics and Assembly Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avenue Therapeutics position performs unexpectedly, Assembly Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Assembly Biosciences will offset losses from the drop in Assembly Biosciences' long position.| Avenue Therapeutics vs. Hoth Therapeutics | Avenue Therapeutics vs. Revelation Biosciences | Avenue Therapeutics vs. Virax Biolabs Group | Avenue Therapeutics vs. Palisade Bio |
| Assembly Biosciences vs. Spero Therapeutics | Assembly Biosciences vs. Achilles Therapeutics PLC | Assembly Biosciences vs. Instil Bio | Assembly Biosciences vs. CytomX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |